|
answer text |
<p>In its evaluations of new health technologies, including for rare diseases, the
National Institute for Health and Care Excellence (NICE) takes into account all health-related
costs and benefits, including evidence of comparative outcomes against existing treatment
options such as radiotherapy. Full details of the process and methods used by NICE
in undertaking evaluations are set out in NICE health technology evaluations: the
manual, published on the NICE website and available at the following link:</p><p><a
href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nice.org.uk%2Fprocess%2Fpmg36%2Fchapter%2Fintroduction-to-health-technology-evaluation&data=05%7C01%7CMD.Support%40dhsc.gov.uk%7C333109cf26904e79aba608dbe7825f03%7C61278c3091a84c318c1fef4de8973a1c%7C1%7C0%7C638358319347196670%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=hNltwwubSKJyLzQAyiKcpnHhf45seq1SehLv59TkbCo%3D&reserved=0"
target="_blank">https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation</a></p>
|
|